Obesity Drugs Enjoy a Much-Needed Winning Str...

Watch Carol and Tim LIVE every day on YouTube: http://bit.ly/3vTiACF.Netflix Inc. delivered fourth-quarter results that largely beat Wall Street estimates but issued a cautious forecast for the months ahead, citing higher program spending and the cost of closing its deal with War ...  Show more

In a piece written for Bloomberg Businessweek magazine, Daron Acemoglu, Institute Professor of MIT's Department of Economics, muses on whether there is a way to better understand the mind and methodology of US President Donald Trump. Acemoglu writes that "most of the (Trump) admi ...  Show more

Bloomberg Opinion Columnist and Former New York Fed President William Dudley discusses the outlook for the labor market and Fed monetary policy. David Riley, BlueBay Asset Management Chief Investment Strategist, says the market is underpricing the Fed. Danny Blanchflower, Dartmou ...  Show more

Pharmaceutical companies and insurance providers are at odds over a new class of drugs that have proven quite effective at helping people living with obesity lose weight. Bloomberg’s Robert Langreth and Emma Court join this episode to share their reporting on recent advancements ...  Show more

Bloomberg BNA's Eleanor Tyler joins Tom Keene and Mike McKee to discuss pharmaceutical mergeres, tax inversions, drug pricing, and the renewed efforts by the Federal Trade Commission to regulate an increasingly complicated industry. Learn more about your ad-choices at https://www ...  Show more

One of the most iconic brands in financial television returns for today's issues and today's world. This week's Wall Street Week features David Westin's interviews with Former Council of Economic Advisers Chairman Glenn Hubbard, Equity Group Investments Founder & Chairman Sam Zel ...  Show more